Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Farmers Insurance
Queensland Health
Baxter
Argus Health
McKesson

Generated: April 19, 2019

DrugPatentWatch Database Preview

Forest Labs Inc Company Profile

« Back to Dashboard

What is the competitive landscape for FOREST LABS INC, and what generic alternatives to FOREST LABS INC drugs are available?

FOREST LABS INC has three approved drugs.

There are seven US patents protecting FOREST LABS INC drugs.

There are thirty-nine patent family members on FOREST LABS INC drugs in twenty-six countries.

Summary for Forest Labs Inc
International Patents:39
US Patents:7
Tradenames:3
Ingredients:1
NDAs:3

Drugs and US Patents for Forest Labs Inc

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs Inc ZENPEP pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022210-007 Mar 25, 2014 RX Yes No 8,562,978 ➤ Try a Free Trial Y ➤ Try a Free Trial
Forest Labs Inc ZENPEP pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022210-004 Aug 27, 2009 RX Yes No 8,221,747 ➤ Try a Free Trial Y ➤ Try a Free Trial
Forest Labs Inc ZENPEP pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022210-004 Aug 27, 2009 RX Yes No 8,562,978 ➤ Try a Free Trial Y ➤ Try a Free Trial
Forest Labs Inc VIOKACE pancrelipase (amylase;lipase;protease) TABLET;ORAL 022542-001 Mar 1, 2012 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Forest Labs Inc ZENPEP pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022210-002 Aug 27, 2009 RX Yes No 8,221,747 ➤ Try a Free Trial Y ➤ Try a Free Trial
Forest Labs Inc ZENPEP pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022210-003 Aug 27, 2009 RX Yes No 8,562,981 ➤ Try a Free Trial ➤ Try a Free Trial
Forest Labs Inc ULTRESA pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022222-001 Mar 1, 2012 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
McKesson
Queensland Health
Daiichi Sankyo
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: